NYSE:MCKHealthcare
Is It Too Late To Consider McKesson (MCK) After Its Strong Multi‑Year Run?
If you are wondering whether McKesson at around US$820 a share is still reasonably priced or starting to look expensive, you are in the right place.
The stock has eased back recently, with a 2.4% decline over the last week and a 0.8% decline over the last month, although the 1 year return sits at 39.2% and the 3 year return at 119.5%.
Recent coverage has focused on McKesson as one of the large distributors at the heart of the U.S. healthcare supply chain. This keeps it in the spotlight...